Patient transcriptomic based in vivo functional genetic dissection of NAFLD for therapeutic target identification
Chronic liver disease is a leading cause of death globally and non-alcoholic fatty liver disease (NAFLD) is put in the spotlight with increasing prevalence. With no effective therapeutics apart from lifestyle modifications and liver transplantation, treatment of NAFLD remains a challenge. As NAFLD i...
Saved in:
Main Author: | Moo, Jia Rong |
---|---|
Other Authors: | - |
Format: | Final Year Project |
Language: | English |
Published: |
Nanyang Technological University
2023
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/166383 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Therapeutic target identification and validation for MASLD via patient transcriptome-driven in vivo genetic screening
by: Lee, Yi Jing
Published: (2024) -
The lipid droplet as a potential therapeutic target in NAFLD
by: Goh, V.J., et al.
Published: (2016) -
Genome wide in-vivo functional genetic screen to identify novel modulators of Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Lian, Ying
Published: (2022) -
NAFLD HUMAN IN-VITRO MODEL FOR NOVEL THERAPEUTIC TARGETS INVESTIGATION
by: LAM DO THUY UYEN HA
Published: (2024) -
Molecular and genetic dissection of dilated cardiomyopathy
by: Hafizah Khalidh
Published: (2015)